Xiyanping

From Infogalactic: the planetary knowledge core
Jump to: navigation, search
Xiyanping
280px
Systematic (IUPAC) name
9-dehydro-17-hydro-andrographolide and sodium 9-dehydro-17-hydro-andrographolide-19-yl sulfate

Xiyanping (喜炎平) is an anti-inflammatory and antiviral preparation developed and licensed for use in China. It is a semi-synthetic injectable product derived from the active component of the plant Andrographis paniculata (Chuan Xin Lian, 穿心蓮),[1] which is used in Traditional Chinese medicine.[2] Xiyanping is primarily composed of 9-dehydro-17-hydro-andrographolide and sodium 9-dehydro-17-hydro-andrographolide-19-yl sulfate.[3] It is used mainly in the treatment of hand, foot and mouth disease, diarrhea, upper respiratory tract infections and viral pneumonia,[4][5][6][7] though one case report suggested it may also be useful in the treatment of Zika fever.[8]

Side effects

Xiyanping injection may be associated with side effects typical of allergic reaction, most commonly erythema and pruritus around the injection site, but more rarely anaphylactic reactions may occur, which can be life-threatening.[9] Also, andrographolide and related derivatives are known to be abortifacient,[10] making xiyanping unsuitable for use in pregnant women.

See also

References

  1. Xiao XW, Fu HZ, Luo YH, Wei XY. Potential anti-angiogenic sulfates of andrographolide. J Asian Nat Prod Res. 2013;15(8):809-18. doi: 10.1080/10286020.2013.803473 PMID 23777373
  2. Chen JK, Chen TT. Chinese Medical Herbology and Pharmacology. Chapter 2, Chuan Xin Lian. pp 214-215. Art of Medicine Press 2012, ISBN 0-9740635-0-9
  3. Chong L, Chen W, Luo Y, Jiang Z. Simultaneous determination of 9-dehydro-17-hydro-andrographolide and sodium 9-dehydro-17-hydro-andrographolide-19-yl sulfate in rat plasma by UHPLC-ESI-MS/MS after administration of xiyanping injection: application to a pharmacokinetic study. Biomed Chromatogr. 2013 Jul;27(7):825-30. doi: 10.1002/bmc.2866 PMID 23355108
  4. Zhang P, Xu H, Ling L, Wu X. Meta analysis of the efficacy of Xiyanping injection in the treatment of autumnal diarrhea in children. Pharmaceutical Care and Research 2012; 12(5):349-353. doi: 10.5428/pcar20120511
  5. Wang J, Ren JX, Xie YM, Wang WW, Hu J, Liao X. Systematic review of xiyanping injection for hand foot mouth disease. (Chinese) Zhongguo Zhong Yao Za Zhi. 2013 Sep;38(18):3215-22. PMID 24471354
  6. Wang ZF, Chen X, Zhang W, Xie YM. Literature review on premarketing and postmarketing evidence of xiyanping injection. (Chinese) Zhongguo Zhong Yao Za Zhi. 2014 Sep;39(18):3637-40. PMID 25532411
  7. Sun SG, Shi YF, Yan H, Li Y, Wang R, Wang SH, Sun XD. Xiyanping Injection in Treatment of Viral Pneumonia in Children: A Meta-analysis of Random Control Trials. Chinese Herbal Medicines. 2015 May; 7(2):173-178. doi: 10.1016/S1674-6384(15)60035-1
  8. Deng Y, Zeng L, Bao W, Xu P, Zhong G. Experience of integrated traditional Chinese and Western medicine in first case of imported Zika virus disease in China. (Chinese) Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2016 Feb;28(2):106-9. doi: 10.3760/cma.j.issn.2095-4352.2016.02.005 PMID 26911940
  9. Wang ZF, Xiang YY, Xie YM. Research on early warning signals of adverse drug reactions to parenterally administered xiyanping based on spontaneous reporting system (SRS) data. (Chinese) Zhongguo Zhong Yao Za Zhi. 2013 Sep;38(18):3008-12. PMID 24471321
  10. See reference 2 above


<templatestyles src="Asbox/styles.css"></templatestyles>